Inventor · disambiguated record
Carlos Alegret-Molina
Also filed as: ALEGRET-MOLINA CARLOS
9 granted patents·2 pending applications·3 citations·filing 2015–2020
75Inventor score
Top patents by PatentIndex Score
11 records- 0180US10246465B2Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE LABOR DR·Filed 2015·Granted Apr 2, 2019·3 cites·21 claims
- 0259US11649248B2Oxadiazaspiro compounds for the treatment of drug abuse and addictionESTEVE PHARMACEUTICALS SA·Filed 2020·Granted May 16, 2023·0 cites·18 claims
- 0355US2020339597A1Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 0448US2019177337A1Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE LABOR DR·Filed 2019·Application pending·0 cites
- 0544US10927128B2Oxadiazaspiro compounds for the treatment of drug abuse and addictionESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Feb 23, 2021·0 cites·22 claims
- 0638US10703765B2Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE LABOR DR·Filed 2015·Granted Jul 7, 2020·0 cites·22 claims
- 0736US10183918B2Oxa-azaspiro compounds having activity against painESTEVE LABOR DR·Filed 2016·Granted Jan 22, 2019·0 cites·19 claims
- 0835US10689398B2OXA-Diazaspiro compounds having activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Jun 23, 2020·0 cites·20 claims
- 0934US10421750B2Substituted morpholine derivatives having activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Sep 24, 2019·0 cites·20 claims
- 1033US10022359B21,9-diazaspiro undecane compounds having multimodal activity against painESTEVE LABOR DR·Filed 2015·Granted Jul 17, 2018·0 cites·15 claims
- 1131US10065971B2Amide derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE LABOR DR·Filed 2015·Granted Sep 4, 2018·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →